Subscribe Now
 Already a subscriber? Log-in!
By subscribing to Laboratory Industry Report, each month you'll get an insider's view of the lab industry's most important business and financial trends, plus predictions for the coming year.
In each issue, you find:
- Comparative data on lab pricing
- Information and explanations describing how to deal with healthcare integration, capitation, technology advances, etc.
- Clear perspectives of how your firm is performing vs. the market at large How publicly-traded lab companies are performing and what their top executives earn
- Updates on late-breaking mergers & acquisitions.
Are you up on what's working—and what's not—for laboratories located in a variety of practice settings-hospital, commercial, group practice sites and network systems?
More importantly, do you know where to turn for business intelligence & insight when you need to know what's happening to key companies, how Wall Street views the industry, or the latest scoop on mergers, buyouts, consolidations and alliances?
Laboratory Industry Report is a must for everyone having a vital stake in today's competitive lab marketplace-owner, director, pathologist, CEO, COO, CFO, general manager, administrator, manager, marketeer, or vendor.
With Laboratory Industry Report, you'll get all the business news & insights which are accurate, objective, reliable, and authoritative. Gain a competitive edge for your company or institution today by subscribing today!
|
|
|
 |
 | LIR February 2008 (full PDF issue) |
| TOP OF THE NEWS
Global M&A climb to $3.9 billion
Sonic continues to acquire U.S. labs
INDUSTRY NEWS
Carilion acquires IPS
LabCorp to acquire Tandem Labs
REGULATORY UPDATE
CMS provides pay for quality reporting
INSIDE THE LAB INDUSTRY
2007 U.S. lab M&A total $3.1 billion
EYE ON JOINT VENTURES
PAML’s new venture in Salt Lake City region
FINANCIAL
Lab stocks down 5% in recent weeks
INDUSTRY BUZZ
Molecular Diagnostics 2008 is a must-attend event
Full Article |
| Sonic Takes Over Labs in New Jersey, Tennessee |
| Australia-based Sonic Healthcare continues to expand its operations in the United States. In January, the Sydney-based lab-testing company acquired American Clinical Services Inc. (ACS), based in New Jersey near the New York metropolitan area, as well as Woodbury Clinical Laboratory, located near Nashville, Tennessee. The purchase price for both labs totals $33 million.
Full Article |
| Global Lab M&A Tops $3.9 Billion, $3.1 Billion in U.S. for ’07 |
| The value of announced global lab-only merger and acquisition (M&A) deals jumped to over $3.9 billion in 2007, up from over $2.1 billion in 2006, according to industry analysis by Crosstree Capital Partners (Tampa, FL). In the United States, there were approximately $3.1 billion in M&A activity and 18 deals, according to Washington G-2 estimates.
Full Article |
| Carilion Labs Acquires Innovative Pathology Services |
| Roanoke, Virginia-based Carilion Labs has acquired Innovative Pathology Services (IPS), an anatomic pathology (AP) and cytology laboratory located in Knoxville, Tennessee.
Full Article |
| CMS Gives Pathologists Incentives for Quality Reporting |
| Beginning this year, many pathologists are eligible for a boost in payment from the Centers for Medicare and Medicaid Services (CMS) under the 2008 Physician Quality Reporting Initiative (PQRI). Even though the agency’s pay-for-reporting program began last year, there were no quality measures for pathologists to report prior to Jan. 1, 2008, when two pathology measures pertaining to breast and colorectal cancer patients were added to the program.
Full Article |
| LabCorp’s Growth Focused on Companion Dx, Managed Care Contracts |
| The country’s number two laboratory testing provider, LabCorp (Burlington, NC), has entered into a definitive agreement to acquire Tandem Labs Inc., a Salt Lake City-based bioanalytical contract research organization (CRO) working with pharmaceutical and biotechnology companies on discovery, preclinical, and clinical drug development programs. Tandem Labs—which also has facilities in West Trenton, New Jersey, and Woburn, Massachusetts—will operate under LabCorp’s Esoterix clinical trials group and will maintain its existing name, along with current employee and management structure. Financial terms of the transaction were not disclosed.
Full Article |
| U.S. Lab M&A Climbs to $3.1B in 2007 |
| Merger and acquisition activity, which included one diagnostic company purchase, continued to keep the lab market a hot one in 2007. According to Washington G-2 estimates, there were 18 announced transactions totaling $3.1 billion, which is up from $2.1 billion in 2006. The number of deals was down from 2006’s total of 25. These totals include a purchase of a diagnostic testing company: Quest’s $420 million acquisition of HemoCue (Angelholm, Sweden), which establishes the company as a larger presence in the point-of-care (POC) testing market.
Full Article |
| PAML’s Newest Joint Venture Focused on Capturing Salt Lake City Outreach Market |
| When St. Mark’s Hospital (Salt Lake City) and Lakeview Hospital (Bountiful, Utah) formed MountainStar Clinical Laboratories as part of their outreach joint venture with Pathology Associates Medical Laboratories (PAML) in November 2007, both labs were doing a combined annual outreach volume of about 100,000 tests. But by the second quarter of this year, hospital leaders anticipate that annual volume will climb to 500,000, as this recent joint venture begins to chip away at the regional market share dominated by Quest and LabCorp, according to St. Mark’s Hospital COO Matt Dixon.
Full Article |
| Lab Stocks Down 5% Over Past 5 Weeks, 1% So Far in '08 |
| Despite a strong start at the beginning of the year, January has been rough on the lab industry, with the G-2 Laboratory Stock Index down 5% over the last five weeks and down 1% for the year for the week ended Jan. 25, 2008. The Nasdaq and S&P 500 also took a beating. Between the weeks ended Dec. 28, 2007, and Jan. 25, 2008, Nasdaq was down 13.02%, while the S&P was down 10%.
Full Article |
| Molecular Diagnostics 2008 Is a Must-Attend Event |
| Don’t miss Washington G-2’s Molecular Diagnostics 2008 Conference. The molecular diagnostic testing market is the fastest-growing and most profitable segment of the $51.7 billion U.S. lab industry. For 2007, Washington G-2 Reports values molecular diagnostic testing at $4.1 billion and estimates growth of approximately 19% each year through 2010. Washington G-2 Reports’ Molecular Diagnostics conference will provide expert insight and advice on how laboratories can and are successfully integrating molecular diagnostics into their business strategies, given the current regulatory business environment. The conference, which will be held April 30 to May 2 at the Hyatt Regency Cambridge in Cambridge, Massachusetts, will feature world-class molecular experts. They include the following invited speakers:
Full Article |
|
|
Please choose an archived issue to view newsletter table of contents above
|
|
